Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Science

• Publication date

  2003-06-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/SCIENCE.1083182PMID 12829775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Neutralizing antiviral antibody responses

  2004cited by this paper
• Structure

  2004cited by this paper
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

  2002cited by this paper
• Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.

  2002cited by this paper
• Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding

  2002cited by this paper
• Antibodies, viruses and vaccines

  2002cited by this paper
• Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides*

  2002cited by this paper
• The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution.

  2002cited by this paper
• 3D domain swapping: As domains continue to swap

  2002cited by this paper
• Neutralizing antibodies against HIV -- back in the major leagues?

  2002cited by this paper
• The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120

  2002cited by this paper
• Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling.

  2002cited by this paper
• Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein

  2002cited by this paper
• The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

  2002cited by this paper
• On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines

  2002cited by this paper
• Structure of an Anti-blood Group A Fv and Improvement of Its Binding Affinity without Loss of Specificity*

  2002cited by this paper
• Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design

  2001cited by this paper
• Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

  2001cited by this paper
• Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5

  2001cited by this paper
• Crystallohydrodynamics for solving the hydration problem for multi-domain proteins: open physiological conformations for human IgG.

  2001cited by this paper
• A Novel Mechanism of Carbohydrate Recognition by the C-type Lectins DC-SIGN and DC-SIGNR

  2001cited by this paper
• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR

  2001cited by this paper
• DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

  2000cited by this paper
• Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41.

  2000cited by this paper
• Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

  2000cited by this paper
• Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.

  1999cited by this paper
• Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.

  1999cited by this paper
• Further additions to MolScript version 1.4, including reading and contouring of electron-density maps.

  1999cited by this paper
• Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120

  1999cited by this paper
• The high degree of internal flexibility observed for an oligomannose oligosaccharide does not alter the overall topology of the molecule.

  1998cited by this paper
• Cell-surface carbohydrate recognition by animal and viral lectins.

  1997cited by this paper
• Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

  1997cited by this paper
• The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.

  1997cited by this paper
• Proline-dependent oligomerization with arm exchange.

  1997cited by this paper
• Raster3D: photorealistic molecular graphics.

  1997cited by this paper
• Glycosylation: heterogeneity and the 3D structure of proteins.

  1997cited by this paper
• An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

  1996cited by this paper
• Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein

  1996cited by this paper
• Accessing the Kabat antibody sequence database by computer

  1996cited by this paper
• Structural basis of lectin-carbohydrate recognition.

  1996cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG

  1995cited by this paper
• A Trojan horse with a sweet tooth

  1995cited by this paper
• Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

  1994cited by this paper
• Crystal structure of a diabody, a bivalent antibody fragment.

  1994cited by this paper
• Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization.

  1994cited by this paper
• Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1

  1994cited by this paper
• Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

  1994cited by this paper
• Shape complementarity at protein/protein interfaces.

  1993cited by this paper
• The molecular surface package.

  1993cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• Sequences of proteins of immunological interest

  1991cited by this paper
• Elbow motion in the immunoglobulins involves a molecular ball-and-socket joint

  1988cited by this paper
• Proteins

  1987cited by this paper
• Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution.

  1987cited by this paper
• Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment.

  1979cited by this paper

• Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies.

  2026cites this paper
• In Vitro Selection of Cyclized, Glycosylated Peptide Antigens That Tightly Bind HIV High Mannose Patch Antibodies

  2025cites this paper
• Probing heterogeneous binding events at single molecule level by single nanoparticle tracking.

  2025cites this paper
• Applications of Nanobodies in Biological Imaging

  2025cites this paper
• Vulnerability in the breadth evolution of an influenza broadly neutralizing antibody

  2025cites this paper
• Structural basis of double-stranded RNA recognition by the J2 monoclonal antibody

  2025influential citation
• Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope.

  2025cites this paper
• Small-angle X-ray scattering of engineered antigen-binding fragments: the case of glycosylated Fab from the Mannitou IgM antibody

  2025cites this paper
• Dynamic and asymmetric colloidal molecules

  2025cites this paper
• iBody-mediated tuning of synthetic cytokine receptor activation via rational nanobody interface engineering

  2025cites this paper
• In vitro selection of cyclized, glycosylated peptide antigens that tightly bind HIV high mannose patch antibodies

  2025cites this paper
• Specificity and mechanism of the double-stranded RNA-specific J2 monoclonal antibody

  2025influential citation
• i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists

  2024influential citation
• Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation

  2024cites this paper
• Complexation-driven assembly of imine-linked helical receptors showing adaptive folding and temperature-dependent guest selection

  2024cites this paper
• Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity

  2024cites this paper
• Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding

  2024cites this paper
• Impact of glycosylation on viral vaccines.

  2024cites this paper
• Antigen‐binding fragments with improved crystal lattice packing and enhanced conformational flexibility at the elbow region as crystallization chaperones

  2024cites this paper
• Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research

  2024cites this paper
• Structural and thermodynamic insights into antibody light chain tetramer formation through 3D domain swapping

  2023cites this paper
• Unveiling the multifaceted landscape of N-glycosylation in antibody variable domains: Insights and implications.

  2023cites this paper
• Editorial: Mechanisms and strategies of unconventional antibody diversification for greater immune adaptability

  2023cites this paper
• Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

  2023cites this paper
• Eliminating the HIV tissue reservoir: current strategies and challenges

  2023cites this paper
• Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

  2023cites this paper
• Harnessing aptamers for the biosensing of cell surface glycans - A review.

  2023cites this paper
• Adjuvants influence the maturation of VRC01-like antibodies during immunization

  2022cites this paper
• Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

  2022cites this paper
• Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies

  2022cites this paper
• Antibody homotypic interactions are encoded by germline light chain complementarity determining region 2

  2022cites this paper
• Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry

  2022cites this paper
• Conserved topology of virus glycoepitopes presents novel targets for repurposing HIV antibody 2G12

  2022cites this paper
• General Strategies for Glycan Microarray Data Processing and Analysis.

  2022cites this paper
• Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors

  2022cites this paper
• Structural and functional analyses of antibodies specific for modified core N‐glycans suggest a role in TH2 responses

  2022cites this paper
• Avidity in antibody effector functions and biotherapeutic drug design

  2022cites this paper
• Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

  2022cites this paper
• Antibody interfaces revealed through structural mining

  2022cites this paper
• Novel Antibody Interfaces Revealed Through Structural Mining

  2022cites this paper
• Conjugation of a Toll‐Like Receptor Agonist to Glycans of an HIV Native‐Like Envelope Trimer Preserves Neutralization Epitopes

  2022cites this paper
• Synthesis and Immunological Study of N-Glycan-Bacteriophage Qβ Conjugates Reveal Dominant Antibody Responses to the Conserved Chitobiose Core.

  2022cites this paper
• Large-Scale Synthesis of Man9GlcNAc2 High-Mannose Glycan and the Effect of the Glycan Core on Multivalent Recognition by HIV Antibody 2G12.

  2022cites this paper
• Adjuvants influence the maturation of VRC01-like antibodies during immunization

  2022cites this paper
• Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller

  2022cites this paper
• Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates.

  2022cites this paper
• Glycans in HIV-1 vaccine design - engaging the shield.

  2022cites this paper
• Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage

  2022cites this paper
• A cross-neutralizing antibody between HIV-1 and influenza virus

  2021influential citation
• Glycan Arrays: Construction, Detection, and Analysis

  2021cites this paper
• Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies

  2021cites this paper
• Strategies and Tactics for the Development of Selective Glycan-Binding Proteins.

  2021cites this paper
• Glycans in Immunologic Health and Disease.

  2021cites this paper
• Dramatic activation of an antibody by a single amino acid change in framework

  2021cites this paper
• Chemoenzymatic Synthesis and Antibody Binding of HIV-1 V1/V2 Glycopeptide-Bacteriophage Qβ Conjugates as a Vaccine Candidate

  2021cites this paper
• Improved resolution in single-molecule localization microscopy using QD-PAINT

  2021cites this paper
• Imaging the Heterogeneous Localization of a Single Molecule.

  2021cites this paper
• Characterization of new recombinant Immunoglobulins type-M binding to C1q by Biolayer Interferometry

  2021cites this paper
• Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity

  2021cites this paper
• A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.

  2021cites this paper
• Glycans in Virus-Host Interactions: A Structural Perspective

  2021cites this paper
• Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment

  2021cites this paper
• Recent advancement in the synthesis of diverse spiro-indeno[1,2-b]quinoxalines: a review

  2021cites this paper
• Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

  2021influential citation
• Variability in the Glycosylation Patterns of gp120 Proteins from Different Human Immunodeficiency Virus Type 1 Isolates Expressed in Different Host Cells.

  2021cites this paper
• New insights of glycosylation role on variable domain of antibody structures

  2021cites this paper
• Synthesis of Mannosidase-Stable Man3 and Man4 Glycans Containing S-linked Manα1→2Man Termini.

  2021cites this paper
• An Octa‐Urea [Pd2L4]4+ Cage that Selectively Binds to n‐octyl‐α‐D‐Mannoside

  2021cites this paper
• Analysis of site-specific glycan profiles of serum proteins in patients with multiple sclerosis or neuromyelitis optica spectrum disorder - a pilot study.

  2021cites this paper
• Directed Evolution of 2'-Fluoro-Modified, RNA-Supported Carbohydrate Clusters That Bind Tightly to HIV Antibody 2G12.

  2021cites this paper
• TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure

  2021cites this paper
• Anti-glycan antibodies: roles in human disease.

  2021cites this paper
• The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans

  2020cites this paper
• Quantifying Protein–Protein Interactions by Molecular Counting with Mass Photometry

  2020cites this paper
• Synthetic carbohydrate-based HIV-1 vaccines.

  2020cites this paper
• The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans

  2020cites this paper
• V Region of IgG Controls the Molecular Properties of the Binding Site for Neonatal Fc Receptor

  2020cites this paper
• HIV-1 neutralisierende Antikörper als Werkzeuge für prophylaktische und therapeutische Impfansätze

  2020cites this paper
• Crystal Structure of a Bivalent Antibody Fab Fragment.

  2020cites this paper
• Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

  2020cites this paper
• Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design.

  2020cites this paper
• Schistosoma mansoni.

  2020cites this paper
• Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike

  2020cites this paper
• A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies

  2020influential citation
• Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure–function relationships

  2020cites this paper
• Steric accessibility of the cleavage sites dictates the proteolytic vulnerability of the anti-HIV-1 antibodies 2F5, 2G12 and PG9 in plants.

  2020cites this paper
• Coronaviruses' sugar shields as vaccine candidates.

  2020cites this paper
• Targeting the N332-supersite of the HIV-1 envelope for vaccine design

  2020cites this paper
• A [Pd2L4]4+ cage complex for n-octyl-β-d-glycoside recognition.

  2020cites this paper
• Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions

  2020cites this paper
• Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

  2020cites this paper
• Comparison of the antiviral activity of the microbicide candidate griffithsin and its tandemers derivatives against different modes of HIV-1 transmission.

  2020cites this paper
• Glycosylation as a tool for rational vaccine design

  2020cites this paper
• Fab-dimerized glycan-reactive antibodies neutralize HIV and are prevalent in humans and rhesus macaques

  2020cites this paper
• Associations between the serum levels of PFOS/PFOA and IgG N-glycosylation in adult or children.

  2020cites this paper
• Probing Single-Molecule Binding Event by the Dynamic Counting and Mapping of Individual Nanoparticles.

  2020cites this paper
• Antibody recognition of bacterial surfaces and extracellular polysaccharides.

  2019cites this paper
• Broadly neutralizing antibodies and vaccine design against HIV-1 infection

  2019cites this paper
• Properties of HIV-1 env and human seminal fluid that determine virus inhibition by antibodies and microbicides

  2019cites this paper
• Antibody responses to viral infections: a structural perspective across three different enveloped viruses

  2019cites this paper